Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Carcinoma, Non-Small-Cell Lung 14Parkinson Disease 4, Autosomal Dominant Lewy Body 9Stomach Neoplasms 3Uterine Cervical Neoplasms 2Urothelial Cancer 2Urinary Bladder Neoplasms 2Mesothelioma 2Head and Neck Neoplasms 2Carcinoma 2Various Advanced Cancer 1Urologic Neoplasms 1Urethral Neoplasms 1Ureteral Neoplasms 1Small Cell Lung Carcinoma 1Ototoxicity 1Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer 1Non Small Cell Lung Cancer NSCLC 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Metastatic Urothelial Cancer 1Lung Neoplasms 1Liver Neoplasms 1Hepatoblastoma 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Transitional Cell 1Bile Duct Neoplasms 1Adenocarcinoma of Lung 1Adenocarcinoma 1

Interventions

selpercatinib 2pembrolizumab 2Cisplatin 2repotrectinib 1pralsetinib 1entrectinib 1Fluorouracil 1Cetuximab 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has announcements × Head and Neck Neoplasms × Cisplatin × Clear all
NCT03765918 2026-05-12

MK-3475-689

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting
714 enrolled 90 charts 1 FDA
Head & Neck

Parkinson Disease 4, Autosomal Dominant Lewy Body, Head and Neck Neoplasms

NCT02358031 2025-07-18

MK-3475-048

Merck Sharp & Dohme LLC

Phase 3 Completed
882 enrolled 50 charts 1 FDA
Head & Neck

Parkinson Disease 4, Autosomal Dominant Lewy Body, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡